SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000945621-16-000407
Filing Date
2016-02-09
Accepted
2016-02-09 14:03:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G intercept13ga12312015.htm SC 13G/A 80687
  Complete submission text file 0000945621-16-000407.txt   82147
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87033 | Film No.: 161398682
SIC: 2834 Pharmaceutical Preparations

Mailing Address 24 PLACE VENDOME PARIS I0 75001
Business Address 24 PLACE VENDOME PARIS I0 75001 0033142865335
Carmignac Gestion (Filed by) CIK: 0001569758 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A